Pharmafile Logo
Pharmafocus logo
Advanced Search

86% of pharma and biotech companies plan to invest in ‘digitally agile’ supply chains in the next 12 months

March 6, 2023
Business Services

LONDON 6th March 2023  86% of pharma and biotech companies say they plan to become more digitally agile, according to …

News
Press release

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease

March 3, 2023
Business Services

Manchester, UK, 3rd March 2023 – Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver …

News
Press release

Globesity: the silent pandemic of the 21st century. Multidisciplinary and new incisionless endoscopic technique may be an effective solution for adult patients.

March 3, 2023
Business Services

London, 03/03/2023- Ahmed is 45 years old and weighed 120 kg. He was always very tired, and would even fall …

News
Press release

Elon Musk’s Neuralink rejected by FDA for human trials

March 3, 2023
Medical Communications

The FDA has reportedly rejected a bid by Elon Musk’s Neuralink in which they proposed the initiation of human testing …

News

FDA grants orphan drug designation to Temferon for glioblastoma multiforme

March 3, 2023
Medical Communications

The FDA has granted Temferon an Orphan Drug Designation (ODD) for use as a therapeutic option for patients with glioblastoma …

News

Eli Lilly signs $40m licensing deal with Confo Therapeutics over neuropathic pain treatment

March 3, 2023
Sales and Marketing

US-based pharmaceutical company Eli Lilly has signed a small licensing deal with Belgian start-up Confo Therapeutics to allow them access …

News

A gene test could guide decisions around chemotherapy for bowel cancer

March 3, 2023
Medical Communications

Scientists from the Institute of Cancer Research London, Imperial College London and the Netherlands Cancer Institute have researched a gene …

News

Positive Results from POLB 001 LPS Human Challenge Trial

March 2, 2023
Business Services

Key Highlights

News
Press release

Sanofi and Sobi celebrate completion of XTEND-Kids phase 3 study

March 2, 2023
Research and Development

A collaborative study between Sanofi and Sobi called XTEND-Kids phase 3 has finished, solidifying the first milestone needed for regulatory …

News

Microba Life Sciences launches next-generation healthcare testing for gastrointestinal health

March 2, 2023
Medical Communications

Australian precision microbiome company Microba Life Sciences has launched its next-generation testing range for gastrointestinal health. MetaXplore has been relaunched …

News

Eli Lilly caps consumer insulin costs at $35

March 2, 2023
Medical Communications

Eli Lilly & Co has announced that it will cap out-of-pocket insulin costs at $35 per month, following a plea …

News

FDA panel backs GSK RSV vaccine ahead of approval

March 2, 2023
Medical Communications

Yesterday, GSK shared that an advisory committee from the FDA voted in support of its respiratory syncytial virus (RSV) vaccine …

News

Menopause Action Plan – How nutritional support can keep female employees at work

March 1, 2023
Business Services

Through simple nutrition and lifestyle changes HR managers could enable women to continue to thrive at work and pursue their …

News
Press release

Ten new companies enter BioInnovation Institute’s Venture Lab program

March 1, 2023
Business Services

COPENHAGEN, Denmark, March 1, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today …

News
Press release

Koa Health appoints Dr Anna Mandeville as UK Clinical Director and Leslie Norwalk to the Supervisory Board

March 1, 2023
Business Services

London, 1st March 2023: Koa Health, a leading global provider of digital mental healthcare solutions, today announces that Dr Anna …

Appointment

PureTech to Present at the Barclays Global Healthcare Conference

March 1, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …

News
Press release

NICE recommends more digital mental health therapies for NHS use

March 1, 2023
Medical Communications

Eight more digital therapies (DTx) for mental health disorders have been recommended by NICE for use by the NHS, following …

News

FDA approves Reata Pharmaceuticals’ first-in-class treatment for Friedreich’s Ataxia

March 1, 2023
Medical Communications

US-based Reata Pharmaceuticals has announced that its first-in-class treatment for Friedreich’s Ataxia (FA), Skyclarys, has been given FDA approval. This …

News

BioNxt Solutions signs clinical study agreement and commences clinical samples manufacture for Parkinson’s disease trial

March 1, 2023
Research and Development

BioNxt Solutions, a bioscience accelerator focused on next-generation drug formulations and delivery systems, has announced the finalisation of its comparative …

News

Sequana Medical shares positive results from phase 1 clinical trial

March 1, 2023
Research and Development

Sequana Medical has shared positive results from its phase 1 trial, CHIHUAHUA, assessing the safety and tolerability of a single …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025